Insider Buying: Sireesh Appajosyula Acquires Additional Shares of Tharimmune Inc (THAR)

On June 20, 2025, Sireesh Appajosyula, the CEO of Tharimmune Inc, purchased 61,496 shares of Tharimmune Inc (THAR, Financial). Following this transaction, the insider now owns a total of 64,868 shares in the company. The details of this transaction can be found in the SEC Filing.
Tharimmune Inc is a biotechnology company focused on developing innovative therapies for immune-related diseases. The company aims to address unmet medical needs through its research and development efforts.
The insider’s recent purchase is part of a broader trend of insider buying at Tharimmune Inc. Over the past year, there have been eight insider purchases and no insider sales. This trend indicates a positive sentiment among insiders regarding the company’s prospects.

The insider transaction history for Tharimmune Inc shows that Sireesh Appajosyula has been actively acquiring shares, with a total of 76,496 shares purchased over the past year and no shares sold.
On the day of the recent purchase, shares of Tharimmune Inc were trading at $1.48 each, resulting in a market cap of $3.486 million. Investors may consider evaluating the company’s GF Value, price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow for a comprehensive understanding of the stock’s valuation.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

MORE IN INSIDE INVESTMENT NEWS

Citigroup beats second-quarter estimates as markets and banking revenues jump

Published: Tuesday, July 15, 2025 · 12:38 PM

JPMorgan Chase tops estimates on stronger-than-expected trading, investment banking

Published: Tuesday, July 15, 2025 · 11:25 AM